Satellos Bioscience INC. S-8 Filing
Ticker: MSLE · Form: S-8 · Filed: Mar 27, 2026 · CIK: 0001421642
Sentiment: neutral
Filing Stats: 2,941 words · 12 min read · ~10 pages · Grade level 16.7 · Accepted 2026-03-27 08:36:06
Filing Documents
- tm269531d1_s8.htm (S-8) — 62KB
- tm269531d1_ex4-1.htm (EX-4.1) — 60KB
- tm269531d1_ex4-2.htm (EX-4.2) — 55KB
- tm269531d1_ex4-3.htm (EX-4.3) — 6KB
- tm269531d1_ex5-1.htm (EX-5.1) — 11KB
- tm269531d1_ex23-2.htm (EX-23.2) — 3KB
- tm269531d1_ex99-1.htm (EX-99.1) — 122KB
- tm269531d1_ex99-2.htm (EX-99.2) — 248KB
- tm269531d1_ex-filingfees.htm (EX-FILING FEES) — 25KB
- tm269531d1_ex4-3img001.jpg (GRAPHIC) — 95KB
- tm269531d1_ex4-3img002.jpg (GRAPHIC) — 89KB
- tm269531d1_ex4-3img003.jpg (GRAPHIC) — 55KB
- tm269531d1_ex4-4img001.jpg (GRAPHIC) — 79KB
- tm269531d1_ex4-4img002.jpg (GRAPHIC) — 173KB
- tm269531d1_ex4-4img003.jpg (GRAPHIC) — 75KB
- tm269531d1_ex4-4img004.jpg (GRAPHIC) — 147KB
- tm269531d1_ex4-4img005.jpg (GRAPHIC) — 42KB
- tm269531d1_ex4-5img001.jpg (GRAPHIC) — 676KB
- tm269531d1_ex4-5img002.jpg (GRAPHIC) — 173KB
- tm269531d1_ex5-1img001.jpg (GRAPHIC) — 8KB
- tm269531d1_ex5-1img002.jpg (GRAPHIC) — 4KB
- 0001104659-26-035734.txt ( ) — 2920KB
- tm269531d1_ex-filingfees_htm.xml (XML) — 10KB
Plan Information
Item 1. Plan Information. The information required by Item 1 of Part I of this registration statement on Form S-8 (the “registration statement”) will be included in documents sent or given to participants in the plans covered by this registration statement pursuant to Rule 428(b)(1) of the Securities Act of 1933, as amended (the “Securities Act”), the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”), and the instructions to Form S-8.
Registrant Information and Employee Plan Annual Information
Item 2. Registrant Information and Employee Plan Annual Information. The written statement required by Item 2 of Part I of this registration statement will be included in documents sent or given to participants in the plans covered by this registration S-8. PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3. Incorporation of Documents by Reference. Satellos Bioscience Inc. (the “Registrant”) is 1934, as amended (the “Exchange Act”), and, in accordance therewith files reports and other information with the Commission. The Registrant hereby incorporates by reference into this registration statement the following documents that have been previously filed (not furnished) with the Commission: (a) The Registrant’s Annual Report on Form 40-F for the fiscal year ended December 31, 2025, filed with the Commission on March 27, 2026 pursuant to Section 15(d) under the Exchange Act; and (b) The description of the Registrant’s common shares contained in the Registrant’s registration statement on Form 8-A (File No. 001-43107), filed with the Commission on February 5, 2026, together with any amendment thereto filed for the purpose of updating such description. In addition, all other documents filed (not furnished) by the Registrant pursuant to Section 13(a), Section 13(c), Section 14 or Section 15(d) of the Exchange Act on or after the date of this registration statement and prior to the filing of a post-effective amendment to this registration statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated in this registration statement by refe
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of Ontario, Canada, on March 27, 2026. SATELLOS BIOSCIENCE INC. By: /s/ Elizabeth Williams, CPA, CA Name: Elizabeth Williams, CPA, CA Title: Chief Financial Officer POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Frank Gleeson, MBA and Elizabeth Williams, CPA, CA, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, including post-effective amendments, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorney-in-fact and agent and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully for all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of them, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated. Signature Title Date /s/ Frank Gleeson, MBA President Chief Executive Officer March 27, 2026 Frank Gleeson, MBA